Annals of Hematology

, Volume 93, Issue 6, pp 1031–1040 | Cite as

The G8 screening tool detects relevant geriatric impairments and predicts survival in elderly patients with a haematological malignancy

Original Article

Abstract

The G8 screening tool was developed to separate fit older cancer patients who were able to receive standard treatment from those that should undergo a geriatric assessment to guide tailoring of therapy. We set out to determine the discriminative power and prognostic value of the G8 in older patients with a haematological malignancy. Between September 2009 and May 2013, a multi-dimensional geriatric assessment was performed in consecutive patients aged ≥67 years diagnosed with blood cancer at the Innsbruck University Hospital. The assessment included (instrumental) activities of daily living, cognition, mood, nutritional status, mobility, polypharmacy and social support. In parallel, the G8 was also administered (cut-off ≤ 14). Using a cut-off of ≥2 impaired domains, 70 % of the 108 included patients were considered as having an impaired geriatric assessment while 61 % had an impaired G8. The G8 lacked discriminative power for impairments on full geriatric assessment: sensitivity 69, specificity 79, positive predictive value 89 and negative predictive value 50 %. However, G8 was an independent predictor of mortality within the first year after inclusion (hazard ratio 3.93; 95 % confidence interval 1.67–9.22, p < 0.001). Remarkably, patients with impaired G8 fared poorly, irrespective of treatment choices (p < 0.001). This is the first report on the clinical and prognostic relevance of G8 in elderly patients with haematological malignancies. Although the G8 lacked discriminative power for outcome of multi-dimensional geriatric assessment, this score appears to be a powerful prognosticator and could potentially represent a useful tool in treatment decisions. This novel finding certainly deserves further exploration.

Keywords

Elderly Geriatric assessment Prognostication Haematological malignancy 

Notes

Acknowledgment

This study was financially supported by Verein Senioren-Krebshilfe.

Conflicts of interest

No potential conflicts of interest related to this manuscript.

Informed consent

Informed consent was obtained from all patients for being included in the study.

References

  1. 1.
    seer.cancer.gov. 2013.Google Scholar
  2. 2.
    Hutchins LF, Unger JM, Crowley JJ, Coltman CA Jr, Albain KS (1999) Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med 341(27):2061–2067PubMedCrossRefGoogle Scholar
  3. 3.
    Stauder R (2012) The challenge of individualised risk assessment and therapy planning in elderly high-risk myelodysplastic syndromes (MDS) patients. Ann Hematol 91(9):1333–1343PubMedCentralPubMedCrossRefGoogle Scholar
  4. 4.
    Extermann M, Aapro M, Bernabei R et al (2005) Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). Crit Rev Oncol Hematol 55(3):241–252PubMedCrossRefGoogle Scholar
  5. 5.
    Hamaker ME, Vos AG, Smorenburg CH, de Rooij SE, van Munster BC (2012) The value of geriatric assessments in predicting treatment tolerance and all-cause mortality in older patients with cancer. Oncologist 17(11):1439–1449PubMedCentralPubMedCrossRefGoogle Scholar
  6. 6.
    Bellera CA, Rainfray M, Mathoulin-Pelissier S et al (2012) Screening older cancer patients: first evaluation of the G-8 geriatric screening tool. Ann Oncol 23(8):2166–2172PubMedCrossRefGoogle Scholar
  7. 7.
    Vellas B, Guigoz Y, Garry PJ et al (1999) The Mini Nutritional Assessment (MNA) and its use in grading the nutritional state of elderly patients. Nutrition 15(2):116–122PubMedCrossRefGoogle Scholar
  8. 8.
    Soubeyran P, Bellera C, Goyard J et al (2011) Validation of the G8 screening tool in geriatric oncology; the ONCODAGE project. J Clin Oncol 29(15S):9001Google Scholar
  9. 9.
    Hamaker ME, Jonker JM, de Rooij SE, Vos AG, Smorenburg CH, van Munster BC (2012) Frailty screening methods for predicting outcome of a comprehensive geriatric assessment in elderly patients with cancer: a systematic review. Lancet Oncol 13(10):e437–e444PubMedCrossRefGoogle Scholar
  10. 10.
    Valentiny C, Kemmler G, Stauder R (2012) Age, sex and gender impact multidimensional geriatric assessment in elderly cancer patients. J Geriatr Oncol 3:17–23CrossRefGoogle Scholar
  11. 11.
    Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatry Res 12(3):189–198CrossRefGoogle Scholar
  12. 12.
    Sheikh JI, Yesavage JA, Brooks JO III et al (1991) Proposed factor structure of the Geriatric Depression Scale. Int Psychogeriatr 3(1):23–28PubMedCrossRefGoogle Scholar
  13. 13.
    Barthel D (1965) Functional evaluation: the Barthel index. Md State Med J 14:61–65PubMedGoogle Scholar
  14. 14.
    Lawton MP, Brody EM (1969) Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 9(3):179–186PubMedCrossRefGoogle Scholar
  15. 15.
    Mathias S, Nayak US, Isaacs B (1986) Balance in elderly patients: the “get-up and go” test. Arch Phys Med Rehabil 67(6):387–389PubMedGoogle Scholar
  16. 16.
    Fydich F, Sommer G, Brahler E, F-SozU (2007) Fragebogen zur sozialen Unterstutzung. Hogrefe Verlag GmbH & Co.; KGGoogle Scholar
  17. 17.
    Swerdlow SH, Campo E, Harris NL et al (2008) WHO classification of tumours of haematopoietic and lymphoid tissue. IARC, LyonGoogle Scholar
  18. 18.
    Miller MD, Paradis CF, Houck PR et al (1992) Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale. Psychiatry Res 41(3):237–248PubMedCrossRefGoogle Scholar
  19. 19.
    Oberaigner W (2007) Errors in survival rates caused by routinely used deterministic record linkage methods. Methods Inf Med 46(6):420–424PubMedGoogle Scholar
  20. 20.
    Horgan AM, Leighl NB, Coate L et al (2012) Impact and feasibility of a comprehensive geriatric assessment in the oncology setting: a pilot study. Am J Clin Oncol 35(4):322–328PubMedCrossRefGoogle Scholar
  21. 21.
    Chaibi P, Magne N, Breton S et al (2011) Influence of geriatric consultation with comprehensive geriatric assessment on final therapeutic decision in elderly cancer patients. Crit Rev Oncol Hematol 79(3):302–307PubMedCrossRefGoogle Scholar
  22. 22.
    Caillet P, Canoui-Poitrine F, Vouriot J et al (2011) Comprehensive geriatric assessment in the decision-making process in elderly patients with cancer: ELCAPA Study. J Clin Oncol 29(27):3636–3642PubMedCrossRefGoogle Scholar
  23. 23.
    Kenis C, Decoster L, Van PK et al (2013) Performance of two geriatric screening tools in older patients with cancer. J Clin Oncol 2013Google Scholar
  24. 24.
    Tucci A, Ferrari S, Bottelli C, Borlenghi E, Drera M, Rossi G (2009) A comprehensive geriatric assessment is more effective than clinical judgment to identify elderly diffuse large cell lymphoma patients who benefit from aggressive therapy. Cancer 115(19):4547–4553PubMedCrossRefGoogle Scholar
  25. 25.
    Hurria A, Togawa K, Mohile SG et al (2011) Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J Clin Oncol 29(25):3457–3465PubMedCentralPubMedCrossRefGoogle Scholar
  26. 26.
    Fried LP, Tangen CM, Walston J et al (2001) Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56(3):M146–M156PubMedCrossRefGoogle Scholar
  27. 27.
    Aaldriks AA, Giltay EJ, le Cessie S et al (2013) Prognostic value of geriatric assessment in older patients with advanced breast cancer receiving chemotherapy. Breast 22:753–760PubMedCrossRefGoogle Scholar
  28. 28.
    Aaldriks AA, Maartense E, le Cessie S (2011) Predictive value of geriatric assessment for patients older than 70 years, treated with chemotherapy. Crit Rev Oncol Hematol 79(2):205–212PubMedCrossRefGoogle Scholar
  29. 29.
    Kristjansson SR, Jordhoy MS, Nesbakken A et al (2010) Which elements of a comprehensive geriatric assessment (CGA) predict post-operative complications and early mortality after colorectal cancer surgery? J Geriatr Oncol 1(2):57–65CrossRefGoogle Scholar
  30. 30.
    Ramsdale EE, Polite N, Bylow KA, Kindler HL, Dale W (2011) Relationship between components of the comprehensive geriatric assessment, chemotherapy dose intensity, and overall survival in a colorectal cancer cohort age 65 and older. J. Clin. Oncol. S9000Google Scholar
  31. 31.
    Kanesvaran R, Li H, Koo KN, Poon D (2011) Analysis of prognostic factors of comprehensive geriatric assessment and development of a clinical scoring system in elderly Asian patients with cancer. J Clin Oncol 29(27):3620–3627PubMedCrossRefGoogle Scholar
  32. 32.
    Soubeyran P, Fonck M, Blanc-Bisson C et al (2012) Predictors of early death risk in older patients treated with first-line chemotherapy for cancer. J Clin Oncol 30(15):1829–1834PubMedCrossRefGoogle Scholar
  33. 33.
    Deschler B, Ihorst G, Platzbecker U et al (2013) Parameters detected by geriatric and quality of life assessment in 195 older patients with myelodysplastic syndromes and acute myeloid leukemia are highly predictive for outcome. Haematologica 98(2):208–216PubMedCentralPubMedCrossRefGoogle Scholar
  34. 34.
    Wildes TM, Ruwe AP, Fournier C et al (2013) Geriatric assessment is associated with completion of chemotherapy, toxicity and survival in older adults with cancer. J Geriatr Oncol 4(3):227–234PubMedCrossRefGoogle Scholar
  35. 35.
    Biesma B, Wymenga AN, Vincent A et al (2011) Quality of life, geriatric assessment and survival in elderly patients with non-small-cell lung cancer treated with carboplatin-gemcitabine or carboplatin-paclitaxel: NVALT-3 a phase III study. Ann Oncol 22(7):1520–1527PubMedCrossRefGoogle Scholar
  36. 36.
    Hamaker ME, Buurman BM, van Munster BC, Kuper IM, Smorenburg CH, de Rooij SE (2011) The value of a comprehensive geriatric assessment for patient care in acutely hospitalized older patients with cancer. Oncologist 16:1403–1412PubMedCentralPubMedCrossRefGoogle Scholar
  37. 37.
    Honecker FU, Wedding U, Rettig K, Huschens S, Bokemeyer C (2009) Use of the Comprehensive Geriatric Assessment (CGA) in elderly patients (pts) with solid tumors to predict mortality. Journal of Clinical Oncology Conference: 2009 Annual Meeting of the American Society of Clinical Oncology, Orlando, 29 May to 2 June 2009 Conference Publication: (var pagings) 27 (15 Suppl 1) (pp 9549):20Google Scholar
  38. 38.
    Klepin HD, Geiger AM, Tooze JA et al (2013) Geriatric assessment predicts survival for older adults receiving induction chemotherapy for acute myelogenous leukemia. Blood 121(21):4287–4294PubMedCrossRefGoogle Scholar
  39. 39.
    Klepin HD, Geiger AM, Tooze JA et al (2011) The feasibility of inpatient geriatric assessment for older adults receiving induction chemotherapy for acute myelogenous leukemia. J Am Geriatr Soc 59(10):1837–1846PubMedCentralPubMedCrossRefGoogle Scholar
  40. 40.
    Studenski S, Perera S, Patel K et al (2011) Gait speed and survival in older adults. JAMA 305(1):50–58PubMedCentralPubMedCrossRefGoogle Scholar
  41. 41.
    Cesari M, Kritchevsky SB, Penninx BW et al (2005) Prognostic value of usual gait speed in well-functioning older people–results from the Health, Aging and Body Composition Study. J Am Geriatr Soc 53(10):1675–1680PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  1. 1.Department of Geriatric MedicineDiakonessenhuisUtrechtThe Netherlands
  2. 2.Department of Internal Medicine V (Haematology and Oncology)Innsbruck Medical UniversityInnsbruckAustria

Personalised recommendations